Study reveals tremendous clinical, economic burden of common chronic liver disease

Non-alcoholic fatty liver disease (NAFLD), the most common liver disease worldwide, is increasing in prevalence and is currently estimated to affect approximately one-quarter of the general population. A new study reveals the clinical and economic burden of NAFLD in the United States and Europe. The findings will help clinicians and policy makers develop strategies to deal with this serious chronic disease.